Search alternatives:
significantly predicted » significantly reduced (Expand Search), significantly reduce (Expand Search), significant predictor (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
predicted decrease » predicted secreted (Expand Search), reported decrease (Expand Search)
significantly predicted » significantly reduced (Expand Search), significantly reduce (Expand Search), significant predictor (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
predicted decrease » predicted secreted (Expand Search), reported decrease (Expand Search)
-
161
This is the raw data used for this study.
Published 2025“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”
-
162
Pre-operative versus post-operative symptoms.
Published 2025“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”
-
163
Patient Demographics.
Published 2025“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”
-
164
Diagnostic Criteria for Human Disharmony Loop.
Published 2025“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”
-
165
-
166
Baseline characteristics and potential independent risk factors for mortality of SFTS.
Published 2025Subjects: -
167
Kinetics of coagulation parameters between the survivors and non-survivors during hospitalization.
Published 2025Subjects: -
168
Restricted cubic spline models depicting the relationship between APTT and mortality risk in SFTS.
Published 2025Subjects: -
169
-
170
-
171
Kaplan-Meier survival analysis curves according to the APTT levels between four groups.
Published 2025Subjects: -
172
Dynamic profile of coagulation parameters between survivors and non-survivors in patients with SFTS.
Published 2025Subjects: -
173
Multivariate logistic regression analysis on the risk factors associated with prolonged APTT.
Published 2025Subjects: -
174
Characteristics and outcomes of participants categorized by serum APTT on admission.
Published 2025Subjects: -
175
-
176
-
177
-
178
-
179
-
180